Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 10, 2009, Pages 1060-1069

  Montano Loza, A J ^a   Tandon, P ^a   Kneteman, N ^a   Bailey, R ^b   Bain, V G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BUDD CHIARI SYNDROME; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SHUNTING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BUDD-CHIARI SYNDROME; CHILD; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, SURGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71949085049     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04134.x     Document Type: Article

References (30)

1. Menon KVN, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004 350 : 578 585.
2. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009 50 : 195 203.
3. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000 31 : 587 591.
4. Murad SD, Valla DC, De Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004 39 : 500 508.
5. Rajani R, Melin T, Björnsson E, et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int 2009 29 : 253 259.
6. Stell DA, McAlister VC, Thorburn D. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States. Liver Transpl 2004 10 : 898 902.
7. Rössle M, Olschewski M, Siegerstetter V, et al. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004 135 : 394 403.
8. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973 60 : 646 649.
9. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007 45 : 797 805.
10. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003 39 : 496 501.
11. Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003 38 : 364 371.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958 53 : 457 481.
13. Peto R, Pike MC. Conservatism of the approximation (0-E)/E in the log rank test for survival data on tumor incidence data. Biometrics 1973 29 : 579 584.
14. Chan YH. Logistic regression analysis. Singapore Med J 2004 45 : 149 153.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982 143 : 29 36.
16. Tavill AS, Wood EJ, Kreel L, et al. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975 68 : 509 518.
17. Rautou PE, Moucari R, Escolano S, et al. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 2009 104 : 1140 1146.
18. Darwish Murad S, Kim WR, de Groen PC, et al. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl 2007 13 : 867 874.
19. Orloff MJ, Daily PO, Orloff SL, et al. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 2000 232 : 340 352.
20. Panis Y, Belghiti J, Valla D, et al. Portosystemic shunt in Budd Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994 115 : 276 281.
21. Orloff MJ, Orloff MS, Daily PO. Long-term results of treatment of Budd-Chiari syndrome with portal decompression. Arch Surg 1992 127 : 1182 1187.
22. Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients Hepatology 1995 21 : 1337 1344.
23. Campbell DA Jr., Rolles K, Jamieson N, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988 166 : 511 518.
24. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 2006 44 : 520 528.
25. Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007 13 : 1285 1294.
26. Ulrich F, Pratschke J, Neumann U, et al. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl 2008 14 : 144 150.
27. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis 2008 28 : 259 269.
28. Bachet JB, Condat B, Hagège H, et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007 46 : 60 8.
29. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008 135 : 808 815.
30. Murad SD, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009 151 : 167 175.